Innoviva Inc (INVA) | Stock Price, Analysis, News, Fundaments & Technical Information

stock

Innoviva Inc

NASDAQ | INVA

18.08

USD

+0.01 (+0.06%)

AT CLOSE (AS OF Apr 3, 2025)

$1.1B

MARKET CAP

50.19

P/E Ratio

0.36

EPS

$21

52 Week High

$14

52 Week Low

LIFE SCIENCES

Sector

INVA Chart

Area

Trade Smarter

Take control of your trading journey with a set of smart tools for serious trades

Backtests

Strategy Backtester designed to automate your backtesting and revolutionize the way you trade

Learn More About Backtests

Scanner

Leverage the power of AI to detect valuable opportunities and gain the most out of the markets.

Learn More About Scanner

Signals

Automate your trading workflow with AI-powered trading signals to execute trades automatically.

Learn More About Signals

Journal

Record your trades and performance to improve your trading with AfterPullback’s Trading Journal

Learn More About Journal

INVA Technicals

Tags:

INVA Earnings

Yearly Income Statement (As of Dec 31, 2023)

Field	Value (USD)
Gross Profit	$171M
Total Revenue	$291M
Cost Of Revenue	$120M
Costof Goods And Services Sold	$49M
Operating Income	$17M
Selling General And Administrative	$98M
Research And Development	$34M
Operating Expenses	$154M
Investment Income Net	-
Net Interest Income	-$19M
Interest Income	$14M
Interest Expense	$19M
Non Interest Income	$310M
Other Non Operating Income	-$5M
Depreciation	-
Depreciation And Amortization	$22M
Income Before Tax	$194M
Income Tax Expense	$14M
Interest And Debt Expense	$19M
Net Income From Continuing Operations	$180M
Comprehensive Income Net Of Tax	$180M
Ebit	$213M
Ebitda	$235M
Net Income	$180M

Revenue & Profitability

Earnings Performance

INVA Financials

Highlights

Balance Sheet

Cash Flow

Income Statement

Yearly

Quarterly

yearly Balance Sheet (As of Dec 31, 2023)

Field	Value (USD)
Total Assets	$1.2B
Total Current Assets	$344M
Cash And Cash Equivalents At Carrying Value	$194M
Cash And Short Term Investments	$204M
Inventory	$41M
Current Net Receivables	$70M
Total Non Current Assets	$699M
Property Plant Equipment	$483K
Accumulated Depreciation Amortization Ppe	-
Intangible Assets	$248M
Intangible Assets Excluding Goodwill	$230M
Goodwill	$18M
Investments	$171M
Long Term Investments	$444M
Short Term Investments	$11M
Other Current Assets	$4.3M
Other Non Current Assets	$3.3M
Total Liabilities	$584M
Total Current Liabilities	$38M
Current Accounts Payable	$6.7M
Deferred Revenue	$1.3M
Current Debt	$0
Short Term Debt	$1.2M
Total Non Current Liabilities	$520M
Capital Lease Obligations	$2.8M
Long Term Debt	$900M
Current Long Term Debt	$0
Long Term Debt Noncurrent	$446M
Short Long Term Debt Total	$446M
Other Current Liabilities	$20M
Other Non Current Liabilities	$72M
Total Shareholder Equity	$675M
Treasury Stock	$394M
Retained Earnings	-$25M
Common Stock	$633K
Common Stock Shares Outstanding	$63M

yearly Cash Flow (As of Dec 31, 2023)

Field	Value (USD)
Operating Cashflow	$141M
Payments For Operating Activities	$13M
Proceeds From Operating Activities	-
Change In Operating Liabilities	$4M
Change In Operating Assets	$12M
Depreciation Depletion And Amortization	$24M
Capital Expenditures	$411K
Change In Receivables	$5.1M
Change In Inventory	$12M
Profit Loss	$180M
Cashflow From Investment	-$67M
Cashflow From Financing	-$172M
Proceeds From Repayments Of Short Term Debt	-
Payments For Repurchase Of Common Stock	$76M
Payments For Repurchase Of Equity	$76M
Payments For Repurchase Of Preferred Stock	-
Dividend Payout	$96M
Dividend Payout Common Stock	$96M
Dividend Payout Preferred Stock	-
Proceeds From Issuance Of Common Stock	$170K
Proceeds From Issuance Of Long Term Debt And Capital Securities Net	-
Proceeds From Issuance Of Preferred Stock	-
Proceeds From Repurchase Of Equity	-$76M
Proceeds From Sale Of Treasury Stock	-
Change In Cash And Cash Equivalents	-
Change In Exchange Rate	-
Net Income	$180M

yearly Income Statement (As of Dec 31, 2023)

Field	Value (USD)
Gross Profit	$171M
Total Revenue	$291M
Cost Of Revenue	$120M
Costof Goods And Services Sold	$49M
Operating Income	$17M
Selling General And Administrative	$98M
Research And Development	$34M
Operating Expenses	$154M
Investment Income Net	-
Net Interest Income	-$19M
Interest Income	$14M
Interest Expense	$19M
Non Interest Income	$310M
Other Non Operating Income	-$5M
Depreciation	-
Depreciation And Amortization	$22M
Income Before Tax	$194M
Income Tax Expense	$14M
Interest And Debt Expense	$19M
Net Income From Continuing Operations	$180M
Comprehensive Income Net Of Tax	$180M
Ebit	$213M
Ebitda	$235M
Net Income	$180M

Dividends

Field	Value
Ex Dividend Date	2015-09-08
Declaration Date	None
Record Date	None
Payment Date	None
Amount	0.25

INVA Profile

Innoviva Inc Profile

Sector: LIFE SCIENCES

Industry: PHARMACEUTICAL PREPARATIONS

Innoviva, Inc. is dedicated to the development and commercialization of pharmaceutical products. The company is headquartered in Burlingame, California.

Most Active

Symbol	Price	Change %	Market Cap	Volume
DMN	$0.02	13.04%	-	706,860,781
NVDA	$103.14	-6.59%	$2.68T	263,349,217
F	$9.55	-5.96%	$39.53B	213,326,329
LCID	$2.32	-3.33%	$7.67B	210,875,217
PTIX	$0.43	91.50%	$4.04M	173,208,693

See more →

Symbol	Price	Change %	Market Cap	Volume
JNJ	$160.56	3.35%	$399.65B	9,908,361
PG	$172.57	1.81%	$399.61B	6,993,394
NVO	$67.60	-0.95%	$308.32B	7,033,051
AZN	$74.03	2.50%	$225.70B	6,150,517
MRK	$86.38	-0.25%	$220.07B	12,113,104

See more →

Top Gainers

Symbol	Price	Change %	Market Cap	Volume
VCIG	$6.06	1,818.33%	$26.40M	302,396
MKTW	$9.19	1,684.81%	$19.91M	117,875
ICCT	$4.38	111.59%	$9.78M	168,784,937
PTIX	$0.43	91.50%	$4.04M	173,208,693
MRM	$0.65	74.84%	$2.91M	51,693,935

See more →

Top Losers

Symbol	Price	Change %	Market Cap	Volume
ALDX	$1.42	-73.33%	$326.91M	20,249,631
RFAC	$2.70	-68.60%	$8.44M	605,339
PKBO	$0.02	-67.86%	$531.87K	66,140
TCBP	$0.50	-67.53%	$360.37K	1,955,586
OMQS	$0.04	-66.36%	$1.50M	950,669